<VariationArchive VariationID="944552" VariationName="NM_003227.4(TFR2):c.2183dup (p.Phe729fs)" VariationType="Duplication" Accession="VCV000944552" Version="6" RecordType="classified" NumberOfSubmissions="2" NumberOfSubmitters="2" DateLastUpdated="2024-02-28" DateCreated="2020-07-16" MostRecentSubmission="2024-02-20">
  <RecordStatus>current</RecordStatus>
  <Species>Homo sapiens</Species>
  <ClassifiedRecord>
    <SimpleAllele AlleleID="924527" VariationID="944552">
      <GeneList>
        <Gene Symbol="TFR2" FullName="transferrin receptor 2" GeneID="7036" HGNC_ID="HGNC:11762" Source="submitted" RelationshipType="within single gene">
          <Location>
            <CytogeneticLocation>7q22.1</CytogeneticLocation>
            <SequenceLocation Assembly="GRCh38" AssemblyAccessionVersion="GCF_000001405.38" AssemblyStatus="current" Chr="7" Accession="NC_000007.14" start="100620420" stop="100641552" display_start="100620420" display_stop="100641552" Strand="-" />
            <SequenceLocation Assembly="GRCh37" AssemblyAccessionVersion="GCF_000001405.25" AssemblyStatus="previous" Chr="7" Accession="NC_000007.13" start="100218038" stop="100239172" display_start="100218038" display_stop="100239172" Strand="-" />
          </Location>
          <OMIM>604720</OMIM>
        </Gene>
      </GeneList>
      <Name>NM_003227.4(TFR2):c.2183dup (p.Phe729fs)</Name>
      <CanonicalSPDI>NC_000007.14:100621079:GGGG:GGGGG</CanonicalSPDI>
      <VariantType>Duplication</VariantType>
      <Location>
        <CytogeneticLocation>7q22.1</CytogeneticLocation>
        <SequenceLocation Assembly="GRCh38" AssemblyAccessionVersion="GCF_000001405.38" forDisplay="true" AssemblyStatus="current" Chr="7" Accession="NC_000007.14" start="100621079" stop="100621080" display_start="100621079" display_stop="100621080" variantLength="1" positionVCF="100621079" referenceAlleleVCF="C" alternateAlleleVCF="CG" />
        <SequenceLocation Assembly="GRCh37" AssemblyAccessionVersion="GCF_000001405.25" AssemblyStatus="previous" Chr="7" Accession="NC_000007.13" start="100218702" stop="100218703" display_start="100218702" display_stop="100218703" variantLength="1" positionVCF="100218702" referenceAlleleVCF="C" alternateAlleleVCF="CG" />
      </Location>
      <ProteinChange>F558fs</ProteinChange>
      <ProteinChange>F729fs</ProteinChange>
      <HGVSlist>
        <HGVS Assembly="GRCh37" Type="genomic, top-level">
          <NucleotideExpression sequenceAccessionVersion="NC_000007.13" sequenceAccession="NC_000007" sequenceVersion="13" change="g.100218706dup" Assembly="GRCh37">
            <Expression>NC_000007.13:g.100218706dup</Expression>
          </NucleotideExpression>
        </HGVS>
        <HGVS Type="coding">
          <NucleotideExpression sequenceAccessionVersion="NM_003227.4" sequenceAccession="NM_003227" sequenceVersion="4" change="c.2183dup" MANESelect="true">
            <Expression>NM_003227.4:c.2183dup</Expression>
          </NucleotideExpression>
          <ProteinExpression sequenceAccessionVersion="NP_003218.2" sequenceAccession="NP_003218" sequenceVersion="2" change="p.Phe729fs">
            <Expression>NP_003218.2:p.Phe729fs</Expression>
          </ProteinExpression>
          <MolecularConsequence ID="SO:0001589" Type="frameshift variant" DB="SO" />
        </HGVS>
        <HGVS Assembly="GRCh38" Type="genomic, top-level">
          <NucleotideExpression sequenceAccessionVersion="NC_000007.14" sequenceAccession="NC_000007" sequenceVersion="14" change="g.100621083dup" Assembly="GRCh38">
            <Expression>NC_000007.14:g.100621083dup</Expression>
          </NucleotideExpression>
        </HGVS>
        <HGVS Type="genomic">
          <NucleotideExpression sequenceAccessionVersion="NG_007989.1" sequenceAccession="NG_007989" sequenceVersion="1" change="g.25471dup">
            <Expression>NG_007989.1:g.25471dup</Expression>
          </NucleotideExpression>
        </HGVS>
        <HGVS Type="coding">
          <NucleotideExpression sequenceAccessionVersion="NM_001206855.3" sequenceAccession="NM_001206855" sequenceVersion="3" change="c.1670dup">
            <Expression>NM_001206855.3:c.1670dup</Expression>
          </NucleotideExpression>
          <ProteinExpression sequenceAccessionVersion="NP_001193784.1" sequenceAccession="NP_001193784" sequenceVersion="1" change="p.Phe558fs">
            <Expression>NP_001193784.1:p.Phe558fs</Expression>
          </ProteinExpression>
          <MolecularConsequence ID="SO:0001589" Type="frameshift variant" DB="SO" />
        </HGVS>
      </HGVSlist>
      <XRefList>
        <XRef Type="rs" ID="1803096138" DB="dbSNP" />
      </XRefList>
    </SimpleAllele>
    <RCVList>
      <RCVAccession Title="NM_003227.4(TFR2):c.2183dup (p.Phe729fs) AND Hereditary hemochromatosis" Accession="RCV001214976" Version="5">
        <ClassifiedConditionList TraitSetID="21210">
          <ClassifiedCondition DB="MedGen" ID="C0392514">Hereditary hemochromatosis</ClassifiedCondition>
        </ClassifiedConditionList>
        <RCVClassifications>
          <GermlineClassification>
            <ReviewStatus>criteria provided, single submitter</ReviewStatus>
            <Description DateLastEvaluated="2023-04-18" SubmissionCount="1">Pathogenic</Description>
          </GermlineClassification>
        </RCVClassifications>
      </RCVAccession>
      <RCVAccession Title="NM_003227.4(TFR2):c.2183dup (p.Phe729fs) AND Hemochromatosis type 3" Accession="RCV003473763" Version="1">
        <ClassifiedConditionList TraitSetID="1502">
          <ClassifiedCondition DB="MedGen" ID="C1858664">Hemochromatosis type 3</ClassifiedCondition>
        </ClassifiedConditionList>
        <RCVClassifications>
          <GermlineClassification>
            <ReviewStatus>criteria provided, single submitter</ReviewStatus>
            <Description DateLastEvaluated="2023-08-24" SubmissionCount="1">Likely pathogenic</Description>
          </GermlineClassification>
        </RCVClassifications>
      </RCVAccession>
    </RCVList>
    <Classifications>
      <GermlineClassification DateLastEvaluated="2023-08-24" NumberOfSubmissions="2" NumberOfSubmitters="2" DateCreated="2020-07-16" MostRecentSubmission="2024-02-20">
        <ReviewStatus>criteria provided, multiple submitters, no conflicts</ReviewStatus>
        <Description>Pathogenic/Likely pathogenic</Description>
        <Citation Type="general">
          <ID Source="PubMed">16424658</ID>
        </Citation>
        <Citation Type="general">
          <ID Source="PubMed">26029709</ID>
        </Citation>
        <DescriptionHistory Dated="2024-02-17">
          <Description>Likely pathogenic</Description>
        </DescriptionHistory>
        <ConditionList>
          <TraitSet ID="1502" Type="Disease" ContributesToAggregateClassification="true">
            <Trait ID="1638" Type="Disease">
              <Name>
                <ElementValue Type="Preferred">Hemochromatosis type 3</ElementValue>
                <XRef ID="Hemochromatosis+type+3/3290" DB="Genetic Alliance" />
                <XRef ID="MONDO:0011417" DB="MONDO" />
              </Name>
              <Name>
                <ElementValue Type="Alternate">Hereditary hemochromatosis type 3</ElementValue>
              </Name>
              <Name>
                <ElementValue Type="Alternate">Hemochromatosis due to defect in transferrin receptor 2</ElementValue>
              </Name>
              <Name>
                <ElementValue Type="Alternate">TFR2-Related Hereditary Hemochromatosis</ElementValue>
                <XRef ID="NBK1349" DB="GeneReviews" />
              </Name>
              <Symbol>
                <ElementValue Type="Preferred">HFE3</ElementValue>
                <XRef Type="MIM" ID="604250" DB="OMIM" />
              </Symbol>
              <AttributeSet>
                <Attribute Type="GARD id" integerValue="10093" />
                <XRef ID="10093" DB="Office of Rare Diseases" />
              </AttributeSet>
              <AttributeSet>
                <Attribute Type="public definition">TFR2-related hereditary hemochromatosis (TFR2-HHC) is characterized by increased intestinal iron absorption resulting in iron accumulation in the liver, heart, pancreas, and endocrine organs. Age of onset is earlier than in HFE-HHC. The majority of individuals present with signs and symptoms of iron overload in the third decade (e.g., weakness, fatigue, abdominal pain, hepatomegaly, arthritis, arthralgia, progressive increase in skin pigmentation). Others present as young adults with nonspecific symptoms and abnormal serum iron studies or as adults with abnormal serum iron studies and signs of organ involvement including cirrhosis, diabetes mellitus, and arthropathy.</Attribute>
                <XRef ID="NBK1349" DB="GeneReviews" />
              </AttributeSet>
              <Citation Type="review" Abbrev="GeneReviews">
                <ID Source="PubMed">20301523</ID>
                <ID Source="BookShelf">NBK1349</ID>
              </Citation>
              <XRef ID="225123" DB="Orphanet" />
              <XRef ID="C1858664" DB="MedGen" />
              <XRef ID="MONDO:0011417" DB="MONDO" />
              <XRef Type="MIM" ID="604250" DB="OMIM" />
            </Trait>
          </TraitSet>
          <TraitSet ID="21210" Type="Disease" ContributesToAggregateClassification="true">
            <Trait ID="33108" Type="Disease">
              <Name>
                <ElementValue Type="Preferred">Hereditary hemochromatosis</ElementValue>
                <XRef ID="Hereditary+hemochromatosis/8521" DB="Genetic Alliance" />
                <XRef ID="MONDO:0006507" DB="MONDO" />
                <XRef ID="35400008" DB="SNOMED CT" />
              </Name>
              <Symbol>
                <ElementValue Type="Preferred">HFE</ElementValue>
                <XRef Type="MIM" ID="235200" DB="OMIM" />
              </Symbol>
              <Symbol>
                <ElementValue Type="Alternate">HH</ElementValue>
                <XRef Type="MIM" ID="235200" DB="OMIM" />
              </Symbol>
              <AttributeSet>
                <Attribute Type="GARD id" integerValue="10746" />
                <XRef ID="10746" DB="Office of Rare Diseases" />
              </AttributeSet>
              <AttributeSet>
                <Attribute Type="public definition">HFE hemochromatosis is characterized by inappropriately high absorption of iron by the small intestinal mucosa. The phenotypic spectrum of HFE hemochromatosis includes: Persons with clinical HFE hemochromatosis, in whom manifestations of end-organ damage secondary to iron overload are present; Individuals with biochemical HFE hemochromatosis, in whom transferrin-iron saturation is increased and the only evidence of iron overload is increased serum ferritin concentration; and Non-expressing p.Cys282Tyr homozygotes, in whom neither clinical manifestations of HFE hemochromatosis nor iron overload are present. Clinical HFE hemochromatosis is characterized by excessive storage of iron in the liver, skin, pancreas, heart, joints, and anterior pituitary gland. In untreated individuals, early symptoms include: abdominal pain, weakness, lethargy, weight loss, arthralgias, diabetes mellitus; and increased risk of cirrhosis when the serum ferritin is higher than 1,000 ng/mL. Other findings may include progressive increase in skin pigmentation, congestive heart failure, and/or arrhythmias, arthritis, and hypogonadism. Clinical HFE hemochromatosis is more common in men than women.</Attribute>
                <XRef ID="NBK1440" DB="GeneReviews" />
              </AttributeSet>
              <AttributeSet>
                <Attribute Type="disease mechanism" integerValue="273">loss of function</Attribute>
                <XRef ID="GTR000603934" DB="Genetic Testing Registry (GTR)" />
              </AttributeSet>
              <Citation Type="review" Abbrev="GeneReviews">
                <ID Source="PubMed">20301613</ID>
                <ID Source="BookShelf">NBK1440</ID>
              </Citation>
              <Citation Type="Translational/Evidence-based" Abbrev="EuroGenetest, 2010">
                <ID Source="pmc">2987432</ID>
              </Citation>
              <Citation Type="general" Abbrev="USPSTF, 2006">
                <ID Source="PubMed">16880462</ID>
              </Citation>
              <Citation Type="general" Abbrev="AASLD, 2011">
                <ID Source="pmc">3149125</ID>
              </Citation>
              <XRef ID="C0392514" DB="MedGen" />
              <XRef ID="MONDO:0006507" DB="MONDO" />
              <XRef Type="Phenotypic series" ID="PS235200" DB="OMIM" />
            </Trait>
          </TraitSet>
        </ConditionList>
      </GermlineClassification>
    </Classifications>
    <ClinicalAssertionList>
      <ClinicalAssertion ID="7854905" SubmissionDate="2023-12-07" DateLastUpdated="2023-12-30" DateCreated="2023-12-30">
        <ClinVarSubmissionID localKey="NM_003227.4:c.2183dup|OMIM:604250" submittedAssembly="GRCh37" />
        <ClinVarAccession Accession="SCV004203675" DateUpdated="2023-12-30" DateCreated="2023-12-30" Type="SCV" Version="1" SubmitterName="Baylor Genetics" OrgID="1006" OrganizationCategory="laboratory" />
        <RecordStatus>current</RecordStatus>
        <Classification DateLastEvaluated="2023-08-24">
          <ReviewStatus>criteria provided, single submitter</ReviewStatus>
          <GermlineClassification>Likely pathogenic</GermlineClassification>
        </Classification>
        <Assertion>variation to disease</Assertion>
        <AttributeSet>
          <Attribute Type="AssertionMethod">ACMG Guidelines, 2015</Attribute>
          <Citation>
            <ID Source="PubMed">25741868</ID>
          </Citation>
        </AttributeSet>
        <ObservedInList>
          <ObservedIn>
            <Sample>
              <Origin>unknown</Origin>
              <Species TaxonomyId="9606">human</Species>
              <AffectedStatus>unknown</AffectedStatus>
            </Sample>
            <Method>
              <MethodType>clinical testing</MethodType>
            </Method>
            <ObservedData>
              <Attribute Type="Description">not provided</Attribute>
            </ObservedData>
          </ObservedIn>
        </ObservedInList>
        <SimpleAllele>
          <VariantType>Variation</VariantType>
          <AttributeSet>
            <Attribute Type="HGVS">NM_003227.4:c.2183dup</Attribute>
          </AttributeSet>
        </SimpleAllele>
        <TraitSet Type="Disease">
          <Trait Type="Disease">
            <XRef DB="OMIM" ID="604250" Type="MIM" />
          </Trait>
        </TraitSet>
        <SubmissionNameList>
          <SubmissionName>SUB13856327</SubmissionName>
        </SubmissionNameList>
      </ClinicalAssertion>
      <ClinicalAssertion ID="2721523" SubmissionDate="2024-02-08" DateLastUpdated="2024-02-20" DateCreated="2020-07-16">
        <ClinVarSubmissionID localKey="7044443|MedGen:C0392514" submittedAssembly="GRCh37" />
        <ClinVarAccession Accession="SCV001386689" DateUpdated="2024-02-20" DateCreated="2020-07-16" Type="SCV" Version="5" SubmitterName="Invitae" OrgID="500031" OrganizationCategory="laboratory" OrgAbbreviation="Invitae" />
        <RecordStatus>current</RecordStatus>
        <Classification DateLastEvaluated="2023-04-18">
          <ReviewStatus>criteria provided, single submitter</ReviewStatus>
          <GermlineClassification>Pathogenic</GermlineClassification>
          <Citation>
            <ID Source="PubMed">16424658</ID>
          </Citation>
          <Citation>
            <ID Source="PubMed">26029709</ID>
          </Citation>
          <Comment>For these reasons, this variant has been classified as Pathogenic. This variant disrupts a region of the TFR2 protein in which other variant(s) (p.Gly792Arg) have been determined to be pathogenic (PMID: 16424658, 26029709). This suggests that this is a clinically significant region of the protein, and that variants that disrupt it are likely to be disease-causing. ClinVar contains an entry for this variant (Variation ID: 944552). This variant has not been reported in the literature in individuals affected with TFR2-related conditions. This variant is not present in population databases (gnomAD no frequency). This sequence change creates a premature translational stop signal (p.Phe729Valfs*63) in the TFR2 gene. While this is not anticipated to result in nonsense mediated decay, it is expected to disrupt the last 73 amino acid(s) of the TFR2 protein.</Comment>
        </Classification>
        <Assertion>variation to disease</Assertion>
        <AttributeSet>
          <Attribute Type="AssertionMethod">Invitae Variant Classification Sherloc (09022015)</Attribute>
          <Citation>
            <ID Source="PubMed">28492532</ID>
          </Citation>
        </AttributeSet>
        <ObservedInList>
          <ObservedIn>
            <Sample>
              <Origin>germline</Origin>
              <Species TaxonomyId="9606">human</Species>
              <AffectedStatus>unknown</AffectedStatus>
            </Sample>
            <Method>
              <MethodType>clinical testing</MethodType>
            </Method>
            <ObservedData>
              <Attribute Type="Description">not provided</Attribute>
            </ObservedData>
          </ObservedIn>
        </ObservedInList>
        <SimpleAllele>
          <GeneList>
            <Gene Symbol="TFR2" />
          </GeneList>
          <VariantType>Variation</VariantType>
          <AttributeSet>
            <Attribute Type="HGVS">NC_000007.13:g.100218702_100218703insG</Attribute>
          </AttributeSet>
        </SimpleAllele>
        <TraitSet Type="Disease">
          <Trait Type="Disease">
            <XRef DB="MedGen" ID="C0392514" Type="CUI" />
          </Trait>
        </TraitSet>
        <SubmissionNameList>
          <SubmissionName>SUB11431369</SubmissionName>
          <SubmissionName>SUB12508014</SubmissionName>
          <SubmissionName>SUB14200314</SubmissionName>
          <SubmissionName>SUB8755776</SubmissionName>
        </SubmissionNameList>
      </ClinicalAssertion>
    </ClinicalAssertionList>
    <TraitMappingList>
      <TraitMapping ClinicalAssertionID="2721523" TraitType="Disease" MappingType="XRef" MappingValue="C0392514" MappingRef="MedGen">
        <MedGen CUI="C0392514" Name="Hereditary hemochromatosis" />
      </TraitMapping>
      <TraitMapping ClinicalAssertionID="7854905" TraitType="Disease" MappingType="XRef" MappingValue="604250" MappingRef="OMIM">
        <MedGen CUI="C1858664" Name="Hemochromatosis type 3" />
      </TraitMapping>
    </TraitMappingList>
  </ClassifiedRecord>
</VariationArchive>

